Rizatriptan Tablet, Film Coated
Product Images NDC 71335-2980

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan (NDC 71335-2980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352980)

Label for Rizatriptan Benzoate Tablets, USP 10 mg film-coated tablets. The label includes the NDC 71335-2980-1 and states the package contains 12 tablets. The product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Macleods Pharmaceuticals Ltd. Storage instructions and dosage guidance are also visible.*

FDA Label Image

Fig-5 (Rizatriptan Fct Figure 5)

A line graph displaying the percentage response with 95% confidence intervals over time, comparing Rizatriptan Benzoate Orally Disintegrating Tablets versus placebo. The x-axis shows hours post stage 2 dose from 0.5 to 2.0 hours, and the y-axis indicates percent response ranging from 0 to 100%.*

FDA Label Image

1 (Rizatriptan Figure One)

A line graph showing the estimated probability of response over time (hours post-dose) for Placebo, Rizatriptan Benzoate Tablets 5 mg, and Rizatriptan Benzoate Tablets 10 mg. The graph displays increasing response probabilities from 0 to 2 hours post-dose, with Rizatriptan 10 mg showing the highest response probability, followed by Rizatriptan 5 mg, and Placebo the lowest.*

FDA Label Image

1 (Rizatriptan Figure Two)

A line graph depicting the estimated probability of remediation or rescue over a 24-hour period post-dose for placebo, Rizatriptan Benzoate Tablets 5 mg, and 10 mg. The x-axis shows hours post-dose from 0 to 24, and the y-axis shows the probability percentage from 0% to 100%. The placebo line rises more steeply initially, followed by the 5 mg and 10 mg Rizatriptan lines, which increase more gradually over time.*

FDA Label Image

1 (Rizatriptan Structure One)

Chemical structure diagram of rizatriptan, showing its molecular connectivity including an indole and pyrazole moiety with additional functional groups and a benzoic acid component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.